| 查看: 355 | 回复: 0 | |||
[交流]
“Metabolite signaling causing fatty liver disease”
|
|
A postdoctoral fellow position available in “Metabolite signaling causing fatty liver disease” A postdoctoral position for 2 years is available in the laboratory of Philipp Kaldis at Lund University (https://portal.research.lu.se/en/persons/philipp-kaldis). We are using a combination of omics-approaches (RNAseq, ChIPseq, metabolomics, and lipidomics) and mouse genetics to study how metabolism is re-wired during liver disease and diabetes as a function of cell division (eLife 9:e63835, Developmental Cell 47:425-438; Hepatol Int. 14:463-474; PLOS Genetics 16:e1009084, for a summary of our current work see: https://researchoutreach.org/art ... ion-liver-beyond/). We are looking for a highly motivated postdoctoral fellow that can drive research projects, wants to further her/his career, and will be collaborating with multiple research groups internationally. We are located at the Lund University Diabetes Center (LUDC), Clinical Research Centre (CRC) in Malmö, Sweden (across the bridge from Copenhagen), which is an excellent environment to do research with many research and clinical groups close by. Requirements: PhD in Cell, Molecular Biology, Biochemistry, or Genetics (less than 3 years since graduation) Experience in metabolism, liver biology, or mouse genetics Enthusiastic, passionate, and hard working Proficient in laboratory techniques like qPCR, cloning, WB, and cell culture Able to communicate in English Interested applicants should send a CV, publication list, a brief description of research interests and experience, and three confidential letters of reference to: Prof. Philipp Kaldis philipp.kaldis@med.lu.se |
回复此楼» 猜你喜欢
广西民族大学化学化工学院化学工程与技术学硕，材料化工专硕调剂名额充足！
已经有0人回复
-
透明质酸酶的作用机制：如何实现药物递送
已经有0人回复
-
化学工程及工业化学论文润色/翻译怎么收费?
已经有111人回复
-
爱思维尔旗下LWT投稿
已经有9人回复
-
替拉扎明为缺氧选择性细胞毒药物研究提供新思路
已经有0人回复
-
拉坦前列腺素(Latanoprost)：前列腺素F2α衍生物如何成为青光眼一线用药
已经有0人回复
-
卟啉家族中的明星分子：MESO-四(3,5-二溴-4-羟基苯基)卟啉的性质与制备
已经有1人回复
-
宠物寄生虫防治：氟雷拉纳阻断GABA受体，持效12周驱杀跳蚤蜱虫
已经有0人回复
-
为呼吸打开通道：依伐卡托的科学之旅
已经有1人回复
-
Dordaviprone（ONC201）：小分子药物在中线胶质瘤中的应用
已经有0人回复
-
依喜替康：新型喜树碱衍生物的研究进展
已经有1人回复
20